Sent withMailchimp
Subject (46)Enhertu approved in EU for HER2+ solid tumours
Preheader (150)Enhertu approved in the EU as first tumour agnostic HER2-directed therapy and antibody drug conjugate for patients with previously treated HER2-positi
TypographyColorsText AnalysisBody Words149
Subject Words8
Body Emojis1
Media AnalysisText Links8
Image Links4
Total Links12
Images6
Technical MetricsPerformancePixel Length, px778 px
X-Spam Score1.6
Preheader OptimizedNo
TimingDay of WeekMonday
TimeOvernight